LC/MS/MS High Sensitivity Bioanalytical Method: Atorvastatin Calcium in Human Plasma

Significance of LC/MS/MS Bioanalytical Method for Atorvastatin

Atorvastatin calcium, a widely prescribed statin for hypercholesterolemia, requires precise quantification in human plasma for pharmacokinetic, bioequivalence and therapeutic drug monitoring studies. High sensitivity and selectivity are vital to detect low drug concentrations and ensure reliable data for cardiovascular risk management.

Objectives and Study Overview

The primary aim was to develop and validate a simple, fast and highly sensitive LC/MS/MS assay for quantitative determination of atorvastatin in human plasma. The study evaluates minimal sample preparation and leverages cutting-edge UHPLC and triple quadrupole MS technologies to achieve low limits of quantitation (LLOQ) and robust performance.

Methodology and Instrumentation

• Sample Preparation: Protein precipitation only, using cooled acetonitrile/methanol (1:1), centrifugation and 0.2 µm filtration.
• UHPLC System: Nexera X2 with Phenomenex Synergi 2.5 µm Polar-RP column (100 mm × 2.0 mm).
• Mobile Phase and Gradient: A = 0.1% formic acid in water, B = 0.1% formic acid in acetonitrile; gradient from 10% B to 95% B over 5 min, total run time 8 min, flow rate 0.3 mL/min, column oven at 40 °C.
• Mass Spectrometry: Shimadzu LCMS-8060 with heated ESI in positive mode; block 400 °C, interface 350 °C, DL 250 °C; collision gas Ar (270 kPa); nebulizing, drying and heating gases as N2 and zero air.

Main Results and Discussion

• Linearity: 10–5000 pg/mL with r² > 0.999.
• Sensitivity: LLOQ of 10 pg/mL post-precipitation (equivalent to 40 pg/mL in plasma) at S/N ≈ 10.
• Accuracy and Precision: QC levels (10, 100, 5000 pg/mL) showed accuracy 87–105% and RSD < 9% (n = 6).
• Recovery and Matrix Effect: Mean recovery ~110%, matrix suppression ~36%, acceptable given simple extraction.
• Reproducibility: Consecutive QC injections demonstrated excellent chromatographic stability and peak shape.

Benefits and Practical Applications

This streamlined assay eliminates solid-phase extraction, reducing sample-handling time, solvent use and cost. High throughput and low LLOQ support bioequivalence, pharmacokinetic profiling and therapeutic drug monitoring workflows in clinical and research laboratories.

Future Trends and Potential Applications

Advances in interface heating, ion optics and data acquisition will further enhance sensitivity and throughput. Integration with automated sample handling, multiplexed assays for statin panels and real-time pharmacokinetic feedback are promising directions for personalized medicine and large-scale clinical studies.

Conclusion

A robust, high-sensitivity LC/MS/MS method for atorvastatin quantification in human plasma was established using minimal sample preparation. The validated assay meets rigorous bioanalytical criteria and enables efficient, cost-effective workflows for drug development and clinical monitoring.

References

• [1] Jiang Wang et al, Journal of Chromatography B, 983–984 (2015) 18–25.
• [2] Ying Zhou et al, Journal of Pharmaceutical and Biomedical Analysis 83 (2013) 101–107.
• [3] Pankaj Partani et al, Journal of Pharmaceutical Analysis 4(1) (2014) 26–36.